From: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting
Statistical models (public)
ACC
BA
SENS
SPEC
PPV
NPV
MCC
KAPPA
RFChEMBL
0.74
0.57
0.26
0.88
0.37
0.81
0.16
0.15
SOHNChEMBL
0.73
0.66
0.54
0.78
0.42
0.86
0.30
0.29